$11.30
-0.29-2.50%
At close: -
$11.01
-0.29-2.57%
After Hours: 4:45 PM EDT
Comments
Loading...
Ginkgo Bioworks Holdings Earnings Estimates, EPS & Revenue | NYSE:DNA | Benzinga
Ginkgo Bioworks Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS
$-1.450
Quarterly Revenue
$38.84M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$230.81M
Analyze the earnings history of Ginkgo Bioworks Holdings using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
DNA | Ginkgo Bioworks Holdings | -$1.08 | -$1.24 | -$1.45 | -16.94% | $89.05M | $38.97M | $38.84M | -0.33% | 11/06/2025 | |
DNA | Ginkgo Bioworks Holdings | -$4.40 | -$1.44 | -$1.10 | 23.61% | $56.21M | $42.16M | $50.00M | 18.60% | 08/07/2025 | |
DNA | Ginkgo Bioworks Holdings | -$3.20 | -$1.23 | -$1.68 | -36.59% | $37.94M | $41.26M | $48.00M | 16.34% | 05/06/2025 | |
DNA | Ginkgo Bioworks Holdings | -$4.28 | -$1.30 | -$2.00 | -53.85% | $34.76M | $44.43M | $43.85M | -1.31% | 02/25/2025 | |
DNA | Ginkgo Bioworks Holdings | -$6.21 | -$2.71 | -$1.08 | 60.15% | $55.43M | $45.00M | $89.05M | 97.88% | 11/12/2024 | |
DNA | Ginkgo Bioworks Holdings | -$3.60 | -$3.20 | -$4.40 | -37.50% | $80.57M | $43.71M | $56.21M | 28.59% | 08/08/2024 | |
DNA | Ginkgo Bioworks Holdings | -$4.40 | -$3.20 | -$3.20 | 0.00% | $80.70M | $46.04M | $37.94M | -17.58% | 05/09/2024 | |
DNA | Ginkgo Bioworks Holdings | -$4.00 | -$4.00 | -$4.40 | -10.00% | $98.28M | $42.50M | $34.76M | -18.22% | 02/29/2024 | |
DNA | Ginkgo Bioworks Holdings | -$16.40 | -$3.60 | -$6.40 | -77.78% | $66.40M | $48.08M | $55.43M | 15.29% | 11/08/2023 | |
DNA | Ginkgo Bioworks Holdings | -$16.40 | -$3.60 | -$3.60 | 0.00% | $144.62M | $71.58M | $80.57M | 12.56% | 08/09/2023 | |
DNA | Ginkgo Bioworks Holdings | -$15.20 | -$3.60 | -$4.40 | -22.22% | $168.41M | $71.68M | $80.70M | 12.59% | 05/10/2023 | |
DNA | Ginkgo Bioworks Holdings | -$0.80 | -$8.40 | -$4.00 | 52.38% | $148.49M | $88.66M | $98.28M | 10.86% | 03/01/2023 | |
DNA | Ginkgo Bioworks Holdings | -$3.20 | -$12.00 | -$16.40 | -36.67% | $77.61M | $60.36M | $66.40M | 10.00% | 11/14/2022 | |
DNA | Ginkgo Bioworks Holdings | -$1.60 | -$1.60 | -$16.40 | -925.00% | $43.64M | $43.64M | $144.62M | 231.42% | 08/15/2022 | |
DNA | Ginkgo Bioworks Holdings | -$2.40 | — | -$15.20 | — | — | $105.68M | $168.41M | 59.35% | 05/16/2022 | |
DNA | Ginkgo Bioworks Holdings | — | -$1.60 | -$0.80 | 50.00% | $32.00M | $94.81M | $148.49M | 56.62% | 03/28/2022 | |
DNA | Ginkgo Bioworks Holdings | -$0.80 | -$1.20 | -$2.80 | -133.33% | $13.30M | $45.75M | $77.61M | 69.64% | 11/15/2021 |
Ginkgo Bioworks Holdings (DNA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-1.45 | $-1.24 | -16.9 % |
| Q2 | 2025-08-07 | $-1.10 | $-1.44 | 23.6 % |
| Q1 | 2025-05-06 | $-1.68 | $-1.23 | -36.6 % |
| Q4 | 2025-02-25 | $-2.00 | $-1.30 | -53.8 % |
Ginkgo Bioworks Holdings (DNA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $38.84M | $38.97M | -0.33 % |
| Q2 | 2025-08-07 | $50.00M | $42.16M | 18.6 % |
| Q1 | 2025-05-06 | $48.00M | $41.26M | 16.3 % |
| Q4 | 2025-02-25 | $43.85M | $44.43M | -1.31 % |
FAQ
When is Ginkgo Bioworks Holdings (NYSE:DNA) reporting earnings?
Ginkgo Bioworks Holdings (DNA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Ginkgo Bioworks Holdings (NYSE:DNA)?
Ginkgo Bioworks Holdings (DNA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3 and the Actual EPS was $-1.45, which missed the estimate of $-1.24.
What were Ginkgo Bioworks Holdings’s (NYSE:DNA) revenues?
Ginkgo Bioworks Holdings (DNA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3 and the Actual Revenue was $38.8M, which missed the estimate of $39M.
Browse earnings estimates, EPS, and revenue on all stocks.
